Discover the ProFound power of our Breast AI Suite at NCBC 2023
March 24-28 | Las Vegas, NV | Booth 106
Learn More
ProFound AI® Risk
Revolutionizing Personalized Screening
Now available for 2D and 3D mammography
Learn More
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
POWERFUL CANCER DETECTION SOLUTIONSInnovative Cancer Therapy solutions
We applaud the FDA’s recent announcement of a national dense breast reporting standard.
Ready to standardize your read? Learn more about PowerLook® Density Assessment.
Discover how our new partnership with Google Health will elevate the performance of our technology and expand access to millions of women worldwide.
Learn More
As seen on:
Breast cancer has finally met its match
Recent News
March 13, 2023
iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023
March 13, 2023
iCAD Announces Leadership Transition
March 1, 2023
New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists' Efficiency and Accuracy
February 9, 2023
iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
January 23, 2023
iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI
» View All News »
Precise and Powerful Healthcare Solutions
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.